Changes of telomerase activity by alternative splicing of full-length and β variants of hTERT in breast cancer patients

SunYoung Rha, Hei Cheul Jeung, Kyu Hyun Park, Jin Ju Kim, Hyuncheol Chung

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Human telomerase reverse transcriptase (hTERT) expression level may not always correlate with telomerase activity. Although the positions of the spliced sites suggest that many of the variants do not code for functional reverse transcriptase, the functions of the spliced variants of hTERT are unknown. We analyzed hTERT splicing patterns with respect to telomerase activity in breast cancer. We examined telomerase activity by telomeric repeat amplification protocol (TRAP) assay and detected spliced variants of hTERT by reverse transcription-polymerase chain reaction (RT-PCR). Of 45 breast cancer patients, 38 (84%) were found to express telomerase activity and 41 (91%) expressed hTERT. In patients with telomerase activity, 14 (37%) expressed all four types of variants (full length, α, β, and α/β). Eleven patients (29%) expressed both the full-length and β variant. Eight patients (22%) expressed the β variant only and 3 (8%) expressed the full-length type only. When comparing telomerase activity to the expression of splicing variants, a tendency was found for lower telomerase activity in patients expressing the β variant only (45 ± 11) versus those expressing all four types (64 ± 32) and those coexpressing the full-length type with the β variant (61 ± 22) (p = 0.06, respectively). In patients with both full-length and β variants coexpression, increment of β variant showed a decreased telomerase activity regardless of the full-length variant expression (p = 0.027). Telomerase activity changed with alternative splicing of the full-length and β variants expression of hTERT in breast cancer.

Original languageEnglish
Pages (from-to)213-220
Number of pages8
JournalOncology Research
Volume18
Issue number5-6
DOIs
Publication statusPublished - 2009 Dec 1

Fingerprint

Telomerase
Alternative Splicing
Breast Neoplasms
human TERT protein
RNA-Directed DNA Polymerase
Reverse Transcription
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{e6b8a6498c764add8a44ea7b23c94ccc,
title = "Changes of telomerase activity by alternative splicing of full-length and β variants of hTERT in breast cancer patients",
abstract = "Human telomerase reverse transcriptase (hTERT) expression level may not always correlate with telomerase activity. Although the positions of the spliced sites suggest that many of the variants do not code for functional reverse transcriptase, the functions of the spliced variants of hTERT are unknown. We analyzed hTERT splicing patterns with respect to telomerase activity in breast cancer. We examined telomerase activity by telomeric repeat amplification protocol (TRAP) assay and detected spliced variants of hTERT by reverse transcription-polymerase chain reaction (RT-PCR). Of 45 breast cancer patients, 38 (84{\%}) were found to express telomerase activity and 41 (91{\%}) expressed hTERT. In patients with telomerase activity, 14 (37{\%}) expressed all four types of variants (full length, α, β, and α/β). Eleven patients (29{\%}) expressed both the full-length and β variant. Eight patients (22{\%}) expressed the β variant only and 3 (8{\%}) expressed the full-length type only. When comparing telomerase activity to the expression of splicing variants, a tendency was found for lower telomerase activity in patients expressing the β variant only (45 ± 11) versus those expressing all four types (64 ± 32) and those coexpressing the full-length type with the β variant (61 ± 22) (p = 0.06, respectively). In patients with both full-length and β variants coexpression, increment of β variant showed a decreased telomerase activity regardless of the full-length variant expression (p = 0.027). Telomerase activity changed with alternative splicing of the full-length and β variants expression of hTERT in breast cancer.",
author = "SunYoung Rha and Jeung, {Hei Cheul} and Park, {Kyu Hyun} and Kim, {Jin Ju} and Hyuncheol Chung",
year = "2009",
month = "12",
day = "1",
doi = "10.3727/096504009X12596189659123",
language = "English",
volume = "18",
pages = "213--220",
journal = "Oncology Research",
issn = "0965-0407",
publisher = "Cognizant Communication Corporation",
number = "5-6",

}

Changes of telomerase activity by alternative splicing of full-length and β variants of hTERT in breast cancer patients. / Rha, SunYoung; Jeung, Hei Cheul; Park, Kyu Hyun; Kim, Jin Ju; Chung, Hyuncheol.

In: Oncology Research, Vol. 18, No. 5-6, 01.12.2009, p. 213-220.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Changes of telomerase activity by alternative splicing of full-length and β variants of hTERT in breast cancer patients

AU - Rha, SunYoung

AU - Jeung, Hei Cheul

AU - Park, Kyu Hyun

AU - Kim, Jin Ju

AU - Chung, Hyuncheol

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Human telomerase reverse transcriptase (hTERT) expression level may not always correlate with telomerase activity. Although the positions of the spliced sites suggest that many of the variants do not code for functional reverse transcriptase, the functions of the spliced variants of hTERT are unknown. We analyzed hTERT splicing patterns with respect to telomerase activity in breast cancer. We examined telomerase activity by telomeric repeat amplification protocol (TRAP) assay and detected spliced variants of hTERT by reverse transcription-polymerase chain reaction (RT-PCR). Of 45 breast cancer patients, 38 (84%) were found to express telomerase activity and 41 (91%) expressed hTERT. In patients with telomerase activity, 14 (37%) expressed all four types of variants (full length, α, β, and α/β). Eleven patients (29%) expressed both the full-length and β variant. Eight patients (22%) expressed the β variant only and 3 (8%) expressed the full-length type only. When comparing telomerase activity to the expression of splicing variants, a tendency was found for lower telomerase activity in patients expressing the β variant only (45 ± 11) versus those expressing all four types (64 ± 32) and those coexpressing the full-length type with the β variant (61 ± 22) (p = 0.06, respectively). In patients with both full-length and β variants coexpression, increment of β variant showed a decreased telomerase activity regardless of the full-length variant expression (p = 0.027). Telomerase activity changed with alternative splicing of the full-length and β variants expression of hTERT in breast cancer.

AB - Human telomerase reverse transcriptase (hTERT) expression level may not always correlate with telomerase activity. Although the positions of the spliced sites suggest that many of the variants do not code for functional reverse transcriptase, the functions of the spliced variants of hTERT are unknown. We analyzed hTERT splicing patterns with respect to telomerase activity in breast cancer. We examined telomerase activity by telomeric repeat amplification protocol (TRAP) assay and detected spliced variants of hTERT by reverse transcription-polymerase chain reaction (RT-PCR). Of 45 breast cancer patients, 38 (84%) were found to express telomerase activity and 41 (91%) expressed hTERT. In patients with telomerase activity, 14 (37%) expressed all four types of variants (full length, α, β, and α/β). Eleven patients (29%) expressed both the full-length and β variant. Eight patients (22%) expressed the β variant only and 3 (8%) expressed the full-length type only. When comparing telomerase activity to the expression of splicing variants, a tendency was found for lower telomerase activity in patients expressing the β variant only (45 ± 11) versus those expressing all four types (64 ± 32) and those coexpressing the full-length type with the β variant (61 ± 22) (p = 0.06, respectively). In patients with both full-length and β variants coexpression, increment of β variant showed a decreased telomerase activity regardless of the full-length variant expression (p = 0.027). Telomerase activity changed with alternative splicing of the full-length and β variants expression of hTERT in breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=77951219259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951219259&partnerID=8YFLogxK

U2 - 10.3727/096504009X12596189659123

DO - 10.3727/096504009X12596189659123

M3 - Article

C2 - 20225759

AN - SCOPUS:77951219259

VL - 18

SP - 213

EP - 220

JO - Oncology Research

JF - Oncology Research

SN - 0965-0407

IS - 5-6

ER -